
Chemical and Pharmaceutical Bulletin p. 1532 - 1537 (1999)
Update date:2022-07-31
Topics:
Akasaka, Kozo
Komatsu, Yuki
Tagami, Katsuya
Shimizu, Toshikazu
Shimomura, Naoyuki
Naka, Hiroshi
Hayashi, Kenji
Negi, Shigeto
An efficient synthetic process for the key intermediate of a new peptidomimetic dual metalloprotease inhibitor, ER-40133, was developed. (5R)- Methyl-6-oxopipecolic acid ester (3a), prepared from L-α,-aminoadipic acid, was chemoselectively reduced to the
View MoreHubei Lingsheng Pharmaceuticals Co., Ltd.
Contact:+86-0710-3538058
Address:Xiangyang City Xiangcheng Economic Development Zone, Hubei Province
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Luoyang Aoda chemical Co.,Ltd.
Contact:+86-379-67518785 67516588
Address:MiaoWan industry district,YanShi City,Henan,China
Tianjin Hedong Red Cliff Chemical Reagent Factory
Contact:+86-022-84780548
Address:Li Ming Zhuang Gong Ye Yuan,Dongli District,Tianjin,China
Contact:86-575-86132822,86-575-86085355
Address:No.418 Dadao West Road,Qixing Street,Xinchang, Zhejiang Province, China.
Doi:10.1016/j.molstruc.2012.12.018
(2013)Doi:10.3109/14756366.2011.653355
(2013)Doi:10.1039/c3ra41640b
(2013)Doi:10.1021/ol400493x
(2013)Doi:10.1016/j.jorganchem.2013.01.013
(2013)Doi:10.1021/om400025h
(2013)